Terp, M. G., Jacobsen, K., Molina, M. A., Karachaliou, N., Beck, H. C., Bertran-Alamillo, J., . . . Ditzel, H. J. (2021). Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells. Nature Portfolio.
Chicago Style (17th ed.) CitationTerp, Mikkel G., et al. Combined FGFR and Akt Pathway Inhibition Abrogates Growth of FGFR1 Overexpressing EGFR-TKI-resistant NSCLC Cells. Nature Portfolio, 2021.
MLA (8th ed.) CitationTerp, Mikkel G., et al. Combined FGFR and Akt Pathway Inhibition Abrogates Growth of FGFR1 Overexpressing EGFR-TKI-resistant NSCLC Cells. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.